Apyx Medical Company Insiders

APYX Stock  USD 1.50  0.18  13.64%   
Apyx Medical employs about 252 people. The company is managed by 12 executives with a total tenure of roughly 80 years, averaging almost 6.0 years of service per executive, having 21.0 employees per reported executive. Break down of Apyx Medical's management performance can provide insight into the company performance.
Charles Goodwin  CEO
CEO, Director
Andrew Makrides  Chairman
Executive Chairman of the Board

Apyx Medical's Insider Buying Vs Selling

50

 
Selling
 
Buying

Latest Trades

2023-12-12Matthew C HillAcquired 2500 @ 2.19View
2023-06-26Todd HornsbyDisposed 15000 @ 7.56View
Monitoring Apyx Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Apyx Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.188) % which means that it has lost $0.188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5826) %, meaning that it created substantial loss on money invested by shareholders. Apyx Medical's management efficiency ratios could be used to measure how well Apyx Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.22 in 2024. Return On Capital Employed is likely to rise to -0.29 in 2024. At this time, Apyx Medical's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 8.2 M in 2024.
Common Stock Shares Outstanding is likely to drop to about 22.4 M in 2024. Net Loss is likely to rise to about (19.8 M) in 2024

Apyx Medical Workforce Comparison

Apyx Medical is number one stock in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 292. Apyx Medical totals roughly 252 in number of employees claiming about 86% of equities under Health Care industry.

Apyx Medical Profit Margins

The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.39.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.370.2698
Significantly Up
Slightly volatile

Apyx Medical Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Apyx Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Apyx Medical Notable Stakeholders

An Apyx Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Apyx Medical often face trade-offs trying to please all of them. Apyx Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Apyx Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Charles IICEO PresidentProfile
Charles GoodwinCEO, DirectorProfile
Andrew MakridesExecutive Chairman of the BoardProfile
Moshe CitronowiczSenior Vice PresidentProfile
Todd HornsbyExecutive Vice PresidentProfile
Tara SembTreasurer CFOProfile
Craig SwandalDirectorProfile
Michael GeraghtyIndependent DirectorProfile
Minnie BaylorHenryDirectorProfile
Lawrence WaldmanIndependent DirectorProfile
John AndresIndependent DirectorProfile
Matthew CPAChief OfficerProfile

About Apyx Medical Management Performance

The success or failure of an entity such as Apyx Medical often depends on how effective the management is. Apyx Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Apyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Apyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.24)(0.22)
Return On Capital Employed(0.30)(0.29)
Return On Assets(0.24)(0.22)
Return On Equity(0.70)(0.67)
The data published in Apyx Medical's official financial statements usually reflect Apyx Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Apyx Medical. For example, before you start analyzing numbers published by Apyx accountants, it's critical to develop an understanding of what Apyx Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Apyx Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Apyx Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Apyx Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apyx Medical. Please utilize our Beneish M Score to check the likelihood of Apyx Medical's management manipulating its earnings.

Apyx Medical Workforce Analysis

Traditionally, organizations such as Apyx Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Apyx Medical within its industry.

Apyx Medical Manpower Efficiency

Return on Apyx Medical Manpower

Revenue Per Employee207.7K
Revenue Per Executive4.4M
Net Loss Per Employee74.3K
Net Loss Per Executive1.6M
Working Capital Per Employee228.7K
Working Capital Per Executive4.8M
When determining whether Apyx Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Apyx Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Apyx Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Apyx Medical Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Apyx Stock analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Apyx Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apyx Medical. If investors know Apyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apyx Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
1.512
Quarterly Revenue Growth
0.163
Return On Assets
(0.19)
Return On Equity
(0.58)
The market value of Apyx Medical is measured differently than its book value, which is the value of Apyx that is recorded on the company's balance sheet. Investors also form their own opinion of Apyx Medical's value that differs from its market value or its book value, called intrinsic value, which is Apyx Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apyx Medical's market value can be influenced by many factors that don't directly affect Apyx Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apyx Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Apyx Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apyx Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.